A novel approach to systematically implement the universal definition of myocardial infarction: insights from the CHAMPION PLATFORM trial-Reference-Cited by-同舟云学术

A novel approach to systematically implement the universal definition of myocardial infarction: insights from the CHAMPION PLATFORM trial

Published:2013-02-23 Issue:17 Volume:99 Page:1282-1287
ISSN:1355-6037
Container-title:Heart
language:en
Short-container-title:Heart

Author:

Leonardi Sergio,Truffa Adriano A M,Neely Megan L,Tricoci Pierluigi,White Harvey D,Gibson C Michael,Wilson Matthew,Stone Gregg W,Harrington Robert A,Bhatt Deepak L,Mahaffey Kenneth W

Publisher

BMJ

Subject

Cardiology and Cardiovascular Medicine

Reference22 articles.

1. Creatine kinase-MB elevation after percutaneous coronary intervention predicts adverse outcomes in patients with acute coronary syndromes;Roe;Eur Heart J,2004

2. Minor myocardial damage and prognosis: are spontaneous and percutaneous coronary intervention-related events different?;Akkerhuis;Circulation,2002

3. Clinical outcomes after detection of elevated cardiac enzymes in patients undergoing percutaneous intervention. IMPACT-II Investigators. Integrilin (eptifibatide) to Minimize Platelet Aggregation and Coronary Thrombosis-II;Tardiff;J Am Coll Cardiol,1999

4. American College of Cardiology/American Heart Association/European Society of Cardiology/World Heart Federation universal definition of myocardial infarction classification system and the risk of cardiovascular death: observations from the TRITON-TIMI 38 trial (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis in Myocardial Infarction 38);Bonaca;Circulation,2012

5. Comparison of the prognosis of spontaneous and percutaneous coronary intervention-related myocardial infarction;Leonardi;J Am Coll Cardiol,2012

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of Investigator-Reported and Clinical Event Committee–Adjudicated Outcome Events in GLASSY;Circulation: Cardiovascular Quality and Outcomes;2021-02

2. Rationale and design of ApoA-I Event Reducing in Ischemic Syndromes II (AEGIS-II): A phase 3, multicenter, double-blind, randomized, placebo-controlled, parallel-group study to investigate the efficacy and safety of CSL112 in subjects after acute myocardial infarction;American Heart Journal;2021-01

3. Central Adjudication Identified Additional and Prognostically Important Myocardial Infarctions in Patients Undergoing Percutaneous Coronary Intervention;Circulation: Cardiovascular Interventions;2019-07

4. Rationale and design of a prospective substudy of clinical endpoint adjudication processes within an investigator-reported randomised controlled trial in patients with coronary artery disease: the GLOBAL LEADERS Adjudication Sub-StudY (GLASSY);BMJ Open;2019-03

5. Definitions of peri-procedural myocardial infarction and the association with one-year mortality: Insights from CHAMPION trials;International Journal of Cardiology;2018-11